Sanofi

Emerald Member: Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patient’s needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi US, with headquarters in Bridgewater, New Jersey, employs 17,000 professionals throughout the country. Our affiliate companies in the United States include Genzyme (rare diseases), Sanofi Pasteur (vaccines), Merial (animal health) and Chattem (consumer healthcare). Through the Sanofi Foundation for North America, we strive to reduce […]

Emerald Member: Sunovion

Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare.

Our track record of discovery, development and commercialization of important therapies includes Brovana® (arformoterol tartrate), Latuda® (lurasidone HCl), and Aptiom® (eslicarbazepine acetate). Our approved therapies also include Utibron™ Neohaler® (indacaterol and glycopyrrolate) Inhalation Powder, Seebri™ Neohaler® (glycopyrrolate) Inhalation Powder, Arcapta® Neohaler® (indacaterol) Inhalation Powder.

Sunovion has […]

Gold Member: Gilead Sciences, Inc.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

Our portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single […]

Gold Member: Novartis

As a science-based and patient-oriented healthcare company, we strive to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis is focused on three divisions with global scale and innovation power – pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.

Gold Member: Pfizer

Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That’s why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them.

We have a leading portfolio of products and medicines that support […]

Gold Member: UCB

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases

Patients are at the heart of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. By fulfilling our commitment, driving innovation, and providing patients a meaningful experience, more impactful solutions are on the horizon. Explore below to learn more about UCB’s innovative solutions on the horizon, our expanding footprint across the United States and information for patients.

Gold: Ultragenyx Pharmaceuticals

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States

Silver Member: Abbott

Every day and around the world, Abbott is discovering new ways to make life better – creating more possibilities for more people through the power of health.

Silver Member: CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat rare and serious conditions that include immunodeficiency and autoimmune diseases, hereditary and acquired bleeding disorders, hereditary angioedema, hereditary emphysema, and in transplantation and critical care.

Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in […]

Silver: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies is a biopharmaceutical company founded on Dr. Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body.

We leverage this intracellular approach to deliver treatments that will be transformative for people living with complex psychiatric and neurologic diseases. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all we do create and deliver.

Our mission is to develop innovative treatments to improve the lives of individuals with neuropsychiatric and […]